Lorazepam Use During Breastfeeding
Lorazepam can be used during breastfeeding, but it should be limited to single or occasional doses rather than as a regular sleep aid, and the infant must be monitored for sedation and feeding difficulties. 1
Key Safety Considerations
The FDA drug label explicitly states that lorazepam has been detected in human breast milk and should not be administered to breastfeeding women unless the expected benefit outweighs the potential risk to the infant 1. Sedation and inability to suckle have occurred in neonates of lactating mothers taking benzodiazepines 1. This is the most authoritative guidance available and must frame all clinical decision-making.
Evidence-Based Approach
Single-Dose Use (Acceptable with Monitoring)
The 2020 Association of Anaesthetists guideline notes that lorazepam, midazolam, and temazepam are shorter-acting benzodiazepines than diazepam 2. While the guideline primarily addresses procedural sedation rather than chronic sleep aid use, it establishes that shorter-acting benzodiazepines have more favorable profiles during lactation.
Research data supports limited exposure:
- A 2021 study measuring benzodiazepine concentrations in breast milk found that lorazepam had a milk-to-plasma ratio <1 and a relative infant dose (RID) <10%, which is generally considered safe 3
- No abnormalities were found in breastfed infants whose mothers received these medications 3
- The published data indicate that levels detected in breast milk are low 4
Chronic Use as Sleep Aid (Not Recommended)
Using lorazepam regularly as a sleep aid during breastfeeding is problematic for several reasons:
Cumulative infant exposure: Repeated dosing increases the risk of drug accumulation in the infant, particularly given the infant's immature hepatic and renal systems 1
Maternal responsiveness concerns: The guideline warns that benzodiazepines may inhibit a mother's natural responsiveness, particularly if she co-sleeps with her infant 2
Withdrawal risk in infant: Prolonged maternal use can lead to infant dependence and withdrawal symptoms 4
Clinical Algorithm for Decision-Making
If a single dose is necessary:
- Use the lowest effective dose (typically 0.5-1 mg for sleep)
- Time the dose immediately after breastfeeding or before the infant's longest sleep period
- Observe the infant for 24-48 hours for sedation, poor feeding, or respiratory depression 1
- Avoid co-sleeping during this period 2
If chronic sleep management is needed, prioritize alternatives:
First-Line Non-Pharmacologic Approaches
- Sleep hygiene optimization
- Cognitive behavioral therapy for insomnia
- Address underlying causes (postpartum depression, anxiety)
Safer Pharmacologic Alternatives
- Antihistamines (diphenhydramine, doxylamine) - though may reduce milk supply
- Melatonin - minimal transfer to breast milk
- Trazodone - low RID, compatible with breastfeeding 5
If Benzodiazepine Required
- Consider midazolam for single-dose use - extensive first-pass metabolism results in low infant blood levels, and breastfeeding can resume as soon as the mother recovers 2
- Avoid diazepam - has active metabolite with prolonged half-life and transfers to breast milk in significant levels 2
Critical Monitoring Parameters
Infants of mothers taking lorazepam must be observed for:
- Sedation or unusual drowsiness
- Poor feeding or inability to suckle
- Respiratory depression
- Hypotonia (floppiness)
- Adequate weight gain 1
If any of these occur, breastfeeding should be temporarily discontinued and the infant evaluated immediately.
Common Pitfalls to Avoid
Don't assume "as needed" use is safe for chronic insomnia - even intermittent use several times per week creates cumulative risk
Don't rely on "pump and dump" - lorazepam has a half-life of 12-18 hours, making timing strategies less effective than with shorter-acting agents
Don't prescribe without pediatric consultation - the infant's pediatrician should be informed and involved in monitoring 6
Don't ignore maternal mental health - if significant anxiety or insomnia persists, address the underlying condition with safer long-term treatments rather than repeated benzodiazepine use 5, 7
Bottom Line
For occasional, single-dose use (e.g., one dose for acute insomnia), lorazepam can be used with careful infant monitoring. For regular sleep aid use, safer alternatives should be strongly preferred. The risk-benefit calculation must prioritize both maternal mental health and infant safety, with the understanding that untreated maternal illness also poses risks to the breastfeeding relationship and infant wellbeing 5, 7.